17 pending office actions • 8 art units • 16 examiners • 0 of 17 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 9 (53%) |
| No statute on record | 8 (47%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VU, QUYNH-NHU HOANG | 2 | 68.2% | +27.9% |
| BLUMEL, BENJAMIN P | 1 | 70.7% | +30.6% |
| BOESEN, AGNIESZKA | 1 | 68.1% | +21.9% |
| ZOU, NIANXIANG | 1 | 64.3% | +24.2% |
| GILL, RACHEL B | 1 | 65.6% | +27.7% |
| OSINSKI, BRADLEY JAMES | 1 | 78.5% | +11.3% |
| KIM, SUN U | 1 | 78.5% | +11.1% |
| JACKSON-TONGUE, LAKIA J | 1 | 68.8% | +20.4% |
| ALAWADI, SARAH | 1 | 37.7% | +38.2% |
| SALVOZA, M FRANCO G | 1 | 69.0% | +29.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18503487 | Vaccines For Human Papilloma Virus And Methods For Using The Same | ZOU, NIANXIANG | 138d overdue |
| 18302522 | METHOD AND DEVICE FOR MINIMALLY INVASIVE IN VIVO TRANSFECTION OF ADIPOSE TISSUE USING ELECTROPORATION | KIM, SUN U | 100d overdue |
| 18656948 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS | BLUMEL, BENJAMIN P | 80d overdue |
| 18526819 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HIV | BOESEN, AGNIESZKA | 78d overdue |
| 16804707 | VARIABLE CURRENT DENSITY SINGLE NEEDLE ELECTROPORATION SYSTEM AND METHOD | VU, QUYNH-NHU HOANG | 37d overdue |
| 18339387 | INTRADERMAL INJECTION DEVICE | VU, QUYNH-NHU HOANG | 16d overdue |
| 18468041 | Vacuum-Assisted Treatment Device, and Related Systems and Methods | OSINSKI, BRADLEY JAMES | 9d |
| 18060048 | IN VIVO USE OF CHONDROITINASE AND/OR HYALURONIDASE TO ENHANCE DELIVERY OF AN AGENT | JACKSON-TONGUE, LAKIA J | 12d |
| Art Unit | Apps |
|---|---|
| 1671 | 4 |
| 3783 | 4 |
| 1672 | 3 |
| 1645 | 2 |
| 1777 | 1 |
| 1619 | 1 |
| 1643 | 1 |
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18656948 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS | BLUMEL, BENJAMIN P | 1671 | Other | Final Rejection | 80d overdue | Pending | May 07, 2024 |
| 18526819 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HIV | BOESEN, AGNIESZKA | 1672 | Other | Non-Final OA | 78d overdue | Pending | Dec 01, 2023 |
| 18503487 | Vaccines For Human Papilloma Virus And Methods For Using The Same | ZOU, NIANXIANG | 1671 | Other | Final Rejection | 138d overdue | Pending | Nov 07, 2023 |
| 18493133 | LASSA VIRUS VACCINE AND USES THEREOF | GILL, RACHEL B | 1671 | Other | Non-Final OA | 34d | Pending | Oct 24, 2023 |
| 18468041 | Vacuum-Assisted Treatment Device, and Related Systems and Methods | OSINSKI, BRADLEY JAMES | 3783 | §103 | Non-Final OA | 9d | Pending | Sep 15, 2023 |
| 18339387 | INTRADERMAL INJECTION DEVICE | VU, QUYNH-NHU HOANG | 3783 | Other | Final Rejection | 16d overdue | Pending | Jun 22, 2023 |
| 18302522 | METHOD AND DEVICE FOR MINIMALLY INVASIVE IN VIVO TRANSFECTION OF ADIPOSE TISSUE USING ELECTROPORATION | KIM, SUN U | 1777 | §103 | Non-Final OA | 100d overdue | Pending | Apr 18, 2023 |
| 18060048 | IN VIVO USE OF CHONDROITINASE AND/OR HYALURONIDASE TO ENHANCE DELIVERY OF AN AGENT | JACKSON-TONGUE, LAKIA J | 1645 | §103 | Final Rejection | 12d | Pending | Nov 30, 2022 |
| 18045575 | TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME | ALAWADI, SARAH | 1619 | Other | Final Rejection | 34d | Pending | Oct 11, 2022 |
| 17813762 | CANCER VACCINES AND METHODS OF TREATMENT USING THE SAME | SALVOZA, M FRANCO G | 1672 | Other | Non-Final OA | 28d | Pending | Jul 20, 2022 |
| 17855349 | Side-Port Injection Devices For Use With Electroporation, and Related Systems and Methods | RODRIGUEZ, CRIS LOIREN | 3783 | §103 | Non-Final OA | 5d overdue | Pending | Jun 30, 2022 |
| 17771736 | IMPROVED VACCINES FOR RECURRENT RESPIRATORY PAPILLOMATOSIS AND METHODS FOR USING THE SAME | FOLEY, SHANON A | 1671 | §103 | Non-Final OA | 9d overdue | Pending | Apr 25, 2022 |
| 17720025 | Methods of Inducing Immune Response Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern | BUCKMASTER, MARLENE VRENI | 1672 | §103 | Final Rejection | 50d overdue | Pending | Apr 13, 2022 |
| 17474389 | Checkpoint Inhibitor and Vaccine Combinations and Use of Same for Immunotherapy | NATARAJAN, MEERA | 1643 | Other | Non-Final OA | 15d overdue | Pending | Sep 14, 2021 |
| 17188648 | VACCINES WITH INTERLEUKIN-33 AS AN ADJUVANT | JIANG, DONG | 1674 | §103 | Non-Final OA | 112d overdue | Pending | Mar 01, 2021 |
| 17063977 | PD1 AND PDL1 ANTIBODIES AND VACCINE COMBINATIONS AND USE OF SAME FOR IMMUNOTHERAPY | HINES, JANA A | 1645 | §103 | Final Rejection | 15d | Pending | Oct 06, 2020 |
| 16804707 | VARIABLE CURRENT DENSITY SINGLE NEEDLE ELECTROPORATION SYSTEM AND METHOD | VU, QUYNH-NHU HOANG | 3783 | §103 | Non-Final OA | 37d overdue | Pending | Feb 28, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial